Strength and dual-task training to help people with Parkinson’s improve strength and function
Official title: Effects of a Multimodal Strength and Dual-Task Program on Sarcopenia and Functional Performance in People With Parkinson's Disease and Parkinsonian Syndromes
Run by University of Valencia · NCT07907302 · Data updated 2026-11-12
This trial tests three levels of physiotherapy, including progressive resistance training with and without cognitive dual-task and instability components, to see if they improve muscle strength, body composition, and physical function in adults with Parkinson’s or related syndromes.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 99 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | University of Valencia Academic / other |
| Locations | 1 site (Valencia, Valencia) |
| Status | Recruiting |
| Started | January 11, 2027 |
| Main results expected | January 29, 2027 |
| Study ends | December 31, 2031 |
| Registry record updated | October 30, 2026 |
| Trial ID | NCT07907302 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with Parkinson’s disease or parkinsonian syndromes, Hoehn and Yahr stage 1-3, able to walk, and on stable medication for at least 4 weeks.
✕Probably not a fit
Patients with advanced disease (Hoehn and Yahr >3), significant comorbidities, or safety concerns for supervised exercise may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, parallel-group randomized trial with three arms comparing different physiotherapy interventions for sarcopenia-related outcomes in adults with Parkinson’s disease or parkinsonian syndromes. Participants are assigned to an Education Group, Progressive Resistance Training (PRT) with cognitive dual-task, or PRT with cognitive dual-task plus instability training. The study integrates nutrition education and supervised exercise, with outcomes focusing on muscle strength, body composition, physical performance, and related domains. Eligibility includes adults with PD or parkinsonism, Hoehn and Yahr 1-3, stable medication, and ability to walk. The lead sponsor is the University of Valencia, with collaboration from CLÍNICA NYR, and the trial is conducted at Clínica NYR in Valencia.
Why it matters
Potential benefit: If successful, patients may experience improved strength, balance, and functional independence, potentially reducing falls and frailty.
How similar studies have gone: Previous resistance training studies show strength and functional gains in Parkinson’s, though integration with a sarcopenia framework and dual-task training is less established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Clinical diagnosis of Parkinson's disease or parkinsonism confirmed by a neurologist. * Hoehn and Yahr stage 1-3. * Age ≥18 years. * Stable antiparkinsonian drug treatment for at least the previous 4 weeks. * Ability to ambulate independently, with or without assistive devices. * Ability to understand and follow basic safety instructions. Exclusion Criteria: * Severe or uncontrolled additional pathology. * Other neurological diseases that interfere with the assessment. * Recent fractures. * Severe dyskinesias or unpredictable motor fluctuations that compromise safety. * Any medical condition that contraindicates supervised physical exercise
Where it's running
-
Clínica NYR
Valencia, Valencia, Spain Recruiting
Study contacts
- Principal investigator: Anna Arnal Gómez, PhD — Department of Physiotherapy, University of Valencia
- Study coordinator: Anna Arnal Gómez, PhD
- Email: anna.arnal@uv.es
- Phone: +34 963983853
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
UX-DA003 injections for Parkinson's disease
This early-phase trial tests whether injecting UX-DA003 is safe and may help motor symptoms in people with Parkinson's whose response to standard treatments has declined.
-
Spinal Mobility, Rigidity, and Kinesiophobia in Parkinson's Disease with and without TMD
This study tests whether people with Parkinson's disease who have Temporomandibular Disorders differ in spinal mobility, axial rigidity, and kinesiophobia from those without TMD.
-
A 12-Week Trial of Flexilev with the OraFID Device and App for Parkinson's
This study tests whether taking small, precise doses of Flexilev with the OraFID dosing device and Levilog app is acceptable and helps people with Parkinson's manage their medicine.
-
Integrated Motor-Cognitive Training in Parkinson's Disease
This study tests a combined motor and cognitive rehabilitation program to see if people with Parkinson’s disease can stick with it and show early signs of benefit.
-
VIM0423 for Parkinson's Tremor in Adults Not Fully Controlled by Dopaminergic Therapy
A Vima Therapeutics study tests whether the oral drug VIM0423 can reduce tremor in adults with Parkinson’s disease who still have tremor despite dopaminergic treatment.
-
Optimizing Adaptive Deep Brain Stimulation for Parkinson's Disease
This study tests whether using ongoing brain signals gathered during daily life can improve adaptive deep brain stimulation for people with Parkinson's who have motor fluctuations.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.